Research programme: G protein-coupled receptor modulator therapeutics - PharmEnable/Nxera Pharma
Latest Information Update: 02 Apr 2024
Price :
$50 *
At a glance
- Originator PharmEnable; Sosei Heptares
- Developer Nxera Pharma; PharmEnable
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurological disorders